Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Antibe Therapeutics completes patient enrollment in OA knee pain trial for ATB-346 Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical… bypharmanewsdailyMarch 2, 2020
